R&D expense · 2017–2025

Biontech R&D expense

$2.4B−2.5% · FY2025

Biontech (BNTX) reported $2.4B in R&D expense for fiscal 2025, −2.5% year on year.

$96.6M2017$169M2018$254M2019$737M2020$1.1B2021$1.6B2022$1.9B2023$2.4B2024$2.4B2025
Biontech — R&D expense, 2017–2025
Fiscal yearR&D expenseChangeFiling
FY20252025-12-31$2.4B−2.5%Open →
FY20242024-12-31$2.4B+26.6%Open →
FY20232023-12-31$1.9B+19.1%Open →
FY20222022-12-31$1.6B+44.2%Open →
FY20212021-12-31$1.1B+52.4%Open →
FY20202020-12-31$737M+190.5%Open →
FY20192019-12-31$254M+50.1%Open →
FY20182018-12-31$169M+74.9%Open →
FY20172017-12-31$96.6M—Open →

R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +49.3%

Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.

R&D expense at companies of similar size

Full ranking by R&D expense →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Biontech R&D expense |url=https://companiesranked.com/en/company/biontech/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Biontech R&D expense. CompaniesRanked. https://companiesranked.com/en/company/biontech/research-and-development-expense

BibTeX

@misc{companiesranked-en-company-biontech-research-and-development-expense-2026,
  author       = {{CompaniesRanked}},
  title        = {{Biontech R\&D expense}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/biontech/research-and-development-expense}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001776985-26-000017 · March 10, 2026

{{cite web |title=Biontech R&D expense — 20-F (0001776985-26-000017) |url=https://www.sec.gov/Archives/edgar/data/1776985/000177698526000017/bntx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-10}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Biontech overview